Octave Bioscience is a company developing a care management platform. Its three-layer model of biological, clinical, and economic data combined with analytics, contextualization, machine learning, and AI provides insights for physicians, patients, payers, and pharma. The company focuses on neurodegenerative diseases including multiple sclerosis.